267 related articles for article (PubMed ID: 8856831)
81. Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination.
Wiley JL; Martin BR
Pharmacol Biochem Behav; 1999 Nov; 64(3):519-22. PubMed ID: 10548265
[TBL] [Abstract][Full Text] [Related]
82. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action.
Ko MC; Woods JH
Psychopharmacology (Berl); 1999 Apr; 143(3):322-6. PubMed ID: 10353438
[TBL] [Abstract][Full Text] [Related]
83. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats.
Moore NL; Greenleaf AL; Acheson SK; Wilson WA; Swartzwelder HS; Kuhn CM
J Pharmacol Exp Ther; 2010 Nov; 335(2):294-301. PubMed ID: 20668056
[TBL] [Abstract][Full Text] [Related]
84. Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats.
Järbe TU; Deng H; Vadivel SK; Makriyannis A
Behav Pharmacol; 2011 Sep; 22(5-6):498-507. PubMed ID: 21836461
[TBL] [Abstract][Full Text] [Related]
85. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
86. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
87. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
Sánchez C; Galve-Roperh I; Canova C; Brachet P; Guzmán M
FEBS Lett; 1998 Sep; 436(1):6-10. PubMed ID: 9771884
[TBL] [Abstract][Full Text] [Related]
88. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Robinson L; Goonawardena AV; Pertwee RG; Hampson RE; Riedel G
Br J Pharmacol; 2007 Jul; 151(5):688-700. PubMed ID: 17502849
[TBL] [Abstract][Full Text] [Related]
89. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
Borgan F; Beck K; Butler E; McCutcheon R; Veronese M; Vernon A; Howes OD
Psychopharmacology (Berl); 2019 Nov; 236(11):3257-3270. PubMed ID: 31165913
[TBL] [Abstract][Full Text] [Related]
90. The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task.
Wise LE; Iredale PA; Lichtman AH
Eur J Pharmacol; 2008 Aug; 590(1-3):246-9. PubMed ID: 18602386
[TBL] [Abstract][Full Text] [Related]
91. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
Dennes RP; Barnes JC
Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
[TBL] [Abstract][Full Text] [Related]
92. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
93. Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates.
Meschler JP; Howlett AC; Madras BK
Psychopharmacology (Berl); 2001 Jun; 156(1):79-85. PubMed ID: 11465637
[TBL] [Abstract][Full Text] [Related]
94. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
Terranova JP; Storme JJ; Lafon N; Péŕio A; Rinaldi-Carmona M; Le Fur G; Soubrié P
Psychopharmacology (Berl); 1996 Jul; 126(2):165-72. PubMed ID: 8856836
[TBL] [Abstract][Full Text] [Related]
95. Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests.
Ennaceur A; Meliani K
Psychopharmacology (Berl); 1992; 109(3):321-30. PubMed ID: 1365633
[TBL] [Abstract][Full Text] [Related]
96. The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.
Hernández-Tristán R; Arévalo C; Canals S; Leret ML
J Physiol Biochem; 2000 Mar; 56(1):17-24. PubMed ID: 10879677
[TBL] [Abstract][Full Text] [Related]
97. Adolescent Δ
Jouroukhin Y; Zhu X; Shevelkin AV; Hasegawa Y; Abazyan B; Saito A; Pevsner J; Kamiya A; Pletnikov MV
Biol Psychiatry; 2019 Jun; 85(11):891-903. PubMed ID: 30219209
[TBL] [Abstract][Full Text] [Related]
98. Chronic Δ9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [
Freeman-Striegel L; Hamilton J; Kannappan R; Bell T; Robison L; Thanos PK
Life Sci; 2023 Aug; 327():121825. PubMed ID: 37270168
[TBL] [Abstract][Full Text] [Related]
99. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat.
Nakamura EM; da Silva EA; Concilio GV; Wilkinson DA; Masur J
Drug Alcohol Depend; 1991 Aug; 28(2):167-75. PubMed ID: 1657563
[TBL] [Abstract][Full Text] [Related]
100. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory.
Egashira N; Mishima K; Katsurabayashi S; Yoshitake T; Matsumoto Y; Ishida J; Yamaguchi M; Iwasaki K; Fujiwara M
Eur J Pharmacol; 2002 Jun; 445(3):221-9. PubMed ID: 12079687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
